Loculated pleural effusion is a condition in which fluid accumulates in the pleural space, the area between the lungs and the chest wall, and becomes trapped in pockets or loculations. This condition is often seen in patients who have had a history of chest trauma or surgery, and can cause respiratory distress and a decrease in lung function. It can also be caused by an infection or an underlying medical condition. Doctors are still trying to unlock the mystery of loculated pleural effusion in order to better diagnose and treat it.
The causes of loculated pleural effusion can be divided into two categories: primary and secondary causes. Primary causes are those that are directly related to the formation of the loculations, such as chest trauma or surgery. Secondary causes are those that cause the fluid to accumulate in the pleural space, such as an infection or an underlying medical condition.
The diagnosis of loculated pleural effusion is often challenging for doctors. Chest X-rays, computed tomography (CT) scans, and ultrasound are all commonly used to diagnose the condition. Chest X-rays can show the presence of fluid in the pleural space, but they are not very accurate in determining the size and shape of the loculations. CT scans are more accurate in determining the size and shape of the loculations, but they are not always available. Ultrasound can also be used to diagnose loculated pleural effusion, but it is not as accurate as CT scans.
The treatment of loculated pleural effusion depends on the underlying cause. If the cause is chest trauma or surgery, the fluid may need to be drained to relieve pressure on the lungs. This is done using a needle or a catheter. If the cause is an infection, antibiotics may be prescribed to treat the infection. If the cause is an underlying medical condition, treatment of the condition may be necessary.
Loculated pleural effusion can lead to a number of complications, including respiratory distress, decreased lung function, and an increased risk of infection. It can also cause pain and discomfort in the chest area. If left untreated, loculated pleural effusion can lead to serious complications, such as lung collapse and atelectasis.
Loculated pleural effusion is a condition in which fluid accumulates in the pleural space and becomes trapped in pockets or loculations. It can be caused by chest trauma or surgery, an infection, or an underlying medical condition. Diagnosis of the condition can be challenging for doctors, and treatment depends on the underlying cause. Loculated pleural effusion can lead to a number of complications, including respiratory distress, decreased lung function, and an increased risk of infection. Doctors are still trying to unlock the mystery of loculated pleural effusion in order to better diagnose and treat it.
1.
What is Mohs micrographic surgery? 8 FAQs about Mohs
2.
The Higher the Disability Burden From Disease, the Higher the Suicide Risk
3.
Older Men Increasingly Overtreated for Prostate Cancer, Study Suggests
4.
Anticoagulation for 12 months has been found to improve outcomes in cancer patients with minor blood clots.
5.
Addition of regional nodal irradiation does not decrease rates of invasive breast cancer recurrence, study finds
1.
Biomimetic Nanovesicles for Breast Cancer: Targeting Senescence to Overcome Chemoresistance
2.
Essential Oncology Updates: Diagnosis, Treatment Advances, Tools & Education Resources
3.
Enhancing Cancer Care: From Diagnosis Through Survivorship and Beyond
4.
Omentum Cancer: Causes, Symptoms, and Treatment Options
5.
Acrochordon: What It Is, Causes, And How To Manage This Skin Condition
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation